Old Web
English
Sign In
Acemap
>
authorDetail
>
Kathleen B. Meyer-Tamaki
Kathleen B. Meyer-Tamaki
University of California, Berkeley
Medicine
Bevacizumab
Infliximab
Trastuzumab
Rituximab
2
Papers
3
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Key Characteristics of Cardiovascular Toxicants.
2021
Environmental Health Perspectives
Lars Lind
Jesus A. Araujo
Aaron Barchowsky
Scott M. Belcher
Brian R. Berridge
Nipavan Chiamvimonvat
Weihsueh A. Chiu
Vincent J. Cogliano
Sarah Elmore
Aimen K. Farraj
Aldrin V. Gomes
Cliona M. McHale
Kathleen B. Meyer-Tamaki
Nikki Gillum Posnack
Hugo M. Vargas
Xi Yang
Lauren Zeise
Changcheng Zhou
Martyn T. Smith
Show All
Source
Cite
Save
Citations (1)
Preclinical Development of Monoclonal Antibodies
2013
Kathleen B. Meyer-Tamaki
Show All
Source
Cite
Save
Citations (2)
1